These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 18339582

  • 1. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS, Rubin BK.
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [Abstract] [Full Text] [Related]

  • 2. Macrolides and airway inflammation in children.
    Shinkai M, Rubin BK.
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [Abstract] [Full Text] [Related]

  • 3. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P, Fabbri LM, Bush A.
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [Abstract] [Full Text] [Related]

  • 4. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE, Rubin BK.
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [Abstract] [Full Text] [Related]

  • 5. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 6. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M, Henke MO, Rubin BK.
    Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
    [Abstract] [Full Text] [Related]

  • 7. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 8. Macrolides in cystic fibrosis.
    McArdle JR, Talwalkar JS.
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [Abstract] [Full Text] [Related]

  • 9. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K, Kastelik J, Morjaria JB.
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [Abstract] [Full Text] [Related]

  • 10. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [Abstract] [Full Text] [Related]

  • 11. [Why use long-term macrolide therapy in pediatric pulmonology?].
    Corvol H, Taytard J, Thouvenin G, Périsson C, Nathan N, Clement A.
    Arch Pediatr; 2014 Mar; 21(3):314-21. PubMed ID: 24503457
    [Abstract] [Full Text] [Related]

  • 12. Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
    Fecik RA, Nguyen PL, Venkatraman L.
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):741-7. PubMed ID: 16312149
    [Abstract] [Full Text] [Related]

  • 13. Macrolide antibiotics as biological response modifiers.
    Rubin BK, Tamaoki J.
    Curr Opin Investig Drugs; 2000 Oct; 1(2):169-72. PubMed ID: 11249569
    [Abstract] [Full Text] [Related]

  • 14. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S, Egan JJ.
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
    [Abstract] [Full Text] [Related]

  • 15. Clinical implications of the immunomodulatory effects of macrolides.
    Tamaoki J, Kadota J, Takizawa H.
    Am J Med; 2004 Nov 08; 117 Suppl 9A():5S-11S. PubMed ID: 15586558
    [Abstract] [Full Text] [Related]

  • 16. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
    Maimon N, Lipton JH, Chan CK, Marras TK.
    Bone Marrow Transplant; 2009 Jul 08; 44(2):69-73. PubMed ID: 19430505
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulatory effects of macrolides: implications for practicing clinicians.
    Siddiqui J.
    Am J Med; 2004 Nov 08; 117 Suppl 9A():26S-29S. PubMed ID: 15586561
    [Abstract] [Full Text] [Related]

  • 18. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V, Bosnar M, Kragol G.
    Future Med Chem; 2014 Apr 08; 6(6):657-74. PubMed ID: 24895894
    [Abstract] [Full Text] [Related]

  • 19. Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
    Majima Y.
    Am J Med; 2004 Nov 08; 117 Suppl 9A():20S-25S. PubMed ID: 15586560
    [Abstract] [Full Text] [Related]

  • 20. Use of macrolides in lung diseases: recent literature controversies.
    Silva Filho LV, Pinto LA, Stein RT.
    J Pediatr (Rio J); 2015 Nov 08; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.